Sep 1, 2026, 01:00 by User Not Found

Clinical Research News | The FDA's Real-Time Clinical Trials (RTCT) initiative is testing whether earlier access to selected clinical trial data can improve regulatory oversight by allowing reviewers to observe selected safety and efficacy signals while studies remain underway. Under the proof-of-concept pilot announced in April, participating sponsors share agreed-upon data elements rather than giving FDA reviewers unrestricted access to complete trial databases.

Aug 28, 2026, 01:00 by User Not Found

Clinical Research News | Clinical research is getting faster. The FDA’s Operation TrialBlazer is explicitly aimed at accelerating and modernizing clinical development, while the agency has also been building toward real-time clinical trials. Faster signal flow is a meaningful advance. It can reduce the delay between what happens in a trial and what regulators or sponsors can see. But it also changes the human work around the data.

Aug 27, 2026, 09:04 by

Inceptua and TikoMed have announced the launch of a Named Patient Program for TikoMed’s investigational drug, ILB®, for eligible patients with Amyotrophic Lateral Sclerosis.

Aug 27, 2026, 09:04 by

Aug 26, 2026, 01:01 by User Not Found

Clinical Research News | Expedition Therapeutics advances its lead COPD treatment into phase 2; Ratio Therapeutics continues a clinical study of a targeted radiotherapeutic for advanced sarcomas; Abcuro prepares to launch a registration-enabling study for inclusion body myositis; and more.

Aug 25, 2026, 08:58 by

New START site to be established within AHN Cancer Center will integrate novel oncology research therapies closer to patients across Western Pennsylvania.

Aug 25, 2026, 01:01 by User Not Found

Clinical Research News | Owkin announced a data collaboration with Kognitic; TrialAssure’s ANONYMIZE platform has been selected by the European Medicines Agency as an official anonymization tool; The Stein Institute for Research on Aging at the University of California San Diego shall serve as the Central Laboratory and Biorepository for the XPRIZE Healthspan Competition; and more.

Aug 19, 2026, 01:02 by User Not Found

Clinical Research News | Since the brain and body are inexorably connected and seem to modulate each other, it follows that the best way to help cancer patients suffering from depression is to view the condition holistically based on their systemic and brain biology and not just their lived experience. To that end, psychedelics like ketamine and psilocybin are actively entering the treatment paradigm.

Aug 18, 2026, 01:01 by User Not Found

Clinical Research News | Digital Immune-Optimized Synthetic vaccines (DIOSynVax) is betting that the future of vaccination lies not in chasing individual viral variants, but in designing broadly protective vaccines that target entire virus families. The University of Cambridge spinout is using artificial intelligence (AI), genomics, synthetic biology, and immunology to create vaccine antigens that could be delivered through a range of existing vaccine platforms, with early clinical data supporting the concept.

Aug 17, 2026, 08:49 by

Aug 13, 2026, 09:53 by

Aug 13, 2026, 09:53 by

Aug 13, 2026, 08:55 by User Not Found

Clinical Research News | Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person.

Aug 12, 2026, 09:02 by

As advances in oncology, cell and gene therapy, and other complex treatments increasingly move care beyond traditional inpatient settings, the ability to continuously monitor patients for early signs of complications is becoming increasingly important. Philips announced a new strategy to expand its open patient monitoring ecosystem through collaborations with select wearable and out-of-hospital technology companies -- including Blue Spark Technologies, which was selected for its best-in-class continuous core body temperature monitoring technology. Blue Spark's TempTraq® wearable patch provides continuous core body temperature monitoring and has been clinically tested in more than 30 studies. Research has demonstrated its ability to detect fevers earlier than routine intermittent temperature monitoring -- an important distinction for patient or clinical trial populations where subtle temperature changes can provide an early warning of infection, inflammation, treatment-related complications, or clinical deterioration.

Aug 12, 2026, 01:01 by User Not Found

Clinical Research News | Investigators at the University of Miami Miller School of Medicine reported that a 19-protein blood biomarker panel, which includes neurofilament light chain (NfL), accurately predicted the transition from presymptomatic disease to clinical amyotrophic lateral sclerosis (ALS), known as phenoconversion, across timeframes ranging from six months to five years.

Aug 11, 2026, 08:39 by

ECI announced today that its Product & Packaging Testing Laboratory, located in the Coyol Free Zone in Costa Rica, has achieved ISO/IEC 17025:2017 accreditation from A2LA for technical competence in mechanical testing.

Aug 11, 2026, 01:01 by User Not Found

Clinical Research News | In the U.K., adversity has brought together 180 clinical trial sites—mostly GP (general practitioner) practices but also community health trusts, hospices, and home care providers—to realize that they have more to gain as collaborators than competitors. The mindset shift prompted the formation of the Primary Care Research Alliance (PCRA), which in the space of 18 months has grown from a core group of 12 practices with 250,000 patients to a network representing 8.5 million and counting.

Aug 10, 2026, 09:11 by

Sanofi’s MenQuadfi has received European Commission approval for use in infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y. The expanded indication is supported by the MET58 pivotal study and clinical data involving more than 6,000 infants across 11 countries. The approval provides EU healthcare professionals with another option for early protection against a rapidly progressing and potentially fatal infection.

Aug 7, 2026, 08:09 by

CellCarta today announced a strategic collaboration with Tempus AI, Inc. (NASDAQ: TEM).

Aug 6, 2026, 09:53 by

Led by a board-certified psychiatrist and 2025 APA Fellow, Headlands Research's new purpose-built site gives sponsors access to more than 615,000 participants in an untapped CNS research market